For millions of people living with chronic hepatitis B, long term treatment has been the only option. “I call hepatitis B the most frequent neglected disease in the world,” said Protzer, who is leading an international team of researchers developing a new vaccine for people living with chronic hepatitis B. While conventional hepatitis B vaccines prevent infection, this therapeutic vaccine is intended for people who are already chronically infected. “Precision medicine for hepatitis B will be a must to optimise the hepatitis B virus cure rates.” “Many people still experience stigma and misunderstanding around hepatitis B.”